Germline TP53 pathogenic variants and breast cancer: A narrative review-Reference-Cited by-同舟云学术

Germline TP53 pathogenic variants and breast cancer: A narrative review

Published:2023-03 Issue: Volume:114 Page:102522
ISSN:0305-7372
Container-title:Cancer Treatment Reviews
language:en
Short-container-title:Cancer Treatment Reviews

Author:

Blondeaux Eva,Arecco Luca,Punie Kevin,Graffeo Rossella,Toss Angela,De Angelis Carmine,Trevisan Lucia,Buzzatti Giulia,Linn Sabine C.,Dubsky Peter,Cruellas Mara,Partridge Ann H.,Balmaña Judith,Paluch-Shimon Shani,Lambertini Matteo

Funder

Gilead Sciences

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Reference111 articles.

1. Breast cancer in young women: rare disease or public health problem?;Rosenberg;JAMA Oncol,2015

2. Understanding mathematical models for breast cancer risk assessment and counseling;Euhus;Breast J,2001

3. Frequency of germline mutations in 25 cancer susceptibility genes in a sequential series of patients with breast cancer;Tung;J Clin Oncol Off J Am Soc Clin Oncol,2016

4. Association studies for finding cancer-susceptibility genetic variants;Pharoah;Nat Rev Cancer,2004

5. Breast Cancer Association Consortium, Dorling L, Carvalho S, Allen J, González-Neira A, Luccarini C, et al. Breast Cancer Risk Genes — Association Analysis in More than 113,000 Women. N Engl J Med. 2021;384(5):428–39.

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multigenic panels in breast cancer: Clinical utility and management of patients with pathogenic variants other than BRCA1/2;Critical Reviews in Oncology/Hematology;2024-09

2. A nomogram based on inflammation and nutritional biomarkers for predicting the survival of breast cancer patients;Frontiers in Endocrinology;2024-08-07

3. Exploring the Mechanism of Myrrh in the Treatment of Breast Cancer Based on Network Pharmacology and Cell Experiments;Chemical Biology & Drug Design;2024-08

4. Myeloid neoplasms in individuals with breast and ovarian cancer and the association with deleterious germline variants;Gynecologic Oncology;2024-08

5. Diagnostic and Practical Challenges in Applying National Comprehensive Cancer Network Guidelines for Suspected Pathogenic TP53 Mosaicism;JCO Precision Oncology;2024-07